Ultragenyx Pharmaceutical | RARE - Ebitda





Ebitda Cambiamento Data
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Agios Pharmaceuticals USD -109.2M 540K 2026-06
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
BioMarin Pharmaceutical USD 222.32M 76.27M 2026-06
Immunic USD -22.78M 753K 2024-06
Insmed USD -80.97M 93.7M 2026-09
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Kyowa Hakko Kirin JPY 34.07B 19.84B 2026-09
MacroGenics USD -64.54M 34.34M 2026-06
Moderna USD -687M 571M 2026-06
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
PTC Therapeutics USD 161.9M 99.92M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06